Cite
HARVARD Citation
Rutter, M. et al. (2020). Recombinant human insulin‐like growth factor‐1 therapy for 6 months improves growth but not motor function in boys with Duchenne muscular dystrophy. Muscle & nerve. 61 (5), pp. 623-631. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rutter, M. et al. (2020). Recombinant human insulin‐like growth factor‐1 therapy for 6 months improves growth but not motor function in boys with Duchenne muscular dystrophy. Muscle & nerve. 61 (5), pp. 623-631. [Online].